Goldman Sachs’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-360
| Closed | -$3.41K | – | 5156 |
|
|
2025
Q1 | $3.41K | Sell |
360
-1,055
| -75% | -$9.98K | ﹤0.01% | 5031 |
|
|
2024
Q4 | $12.7K | Buy |
1,415
+731
| +107% | +$6.56K | ﹤0.01% | 4935 |
|
|
2024
Q3 | $43.9K | Sell |
684
-483
| -41% | -$31K | ﹤0.01% | 4673 |
|
|
2024
Q2 | $87.5K | Buy |
+1,167
| New | +$87.5K | ﹤0.01% | 4510 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$16K | – | 4497 |
|
|
2015
Q4 | $16K | Hold |
1
| – | – | ﹤0.01% | 4366 |
|
|
2015
Q3 | $50K | Hold |
1
| – | – | ﹤0.01% | 4339 |
|
|
2015
Q2 | $79K | Hold |
1
| – | – | ﹤0.01% | 4352 |
|
|
2015
Q1 | $74K | Sell |
1
-1
| -50% | -$74K | ﹤0.01% | 4213 |
|
|
2014
Q4 | $193K | Buy |
+2
| New | +$193K | ﹤0.01% | 3992 |
|